Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 18 October 2023, 09:18 HKT/SGT

Source: Fujitsu Ltd
Fujitsu and TOPPAN Holdings collaborate to expand medical big data business
Utilizing anonymized electronic medical record data to contribute to drug development and medical support

TOKYO, Oct 18, 2023 - (JCN Newswire) - Fujitsu Limited and TOPPAN Holdings Inc. today concluded a business alliance agreement to jointly promote the medical big data business with the aim of promoting research and development utilizing medical big data under Japan’s Next Generation Medical Infrastructure Act (1) and realizing a healthy and long-lived society by creating new industries and businesses.

By combining TOPPAN Holdings' analytical technology with Fujitsu's data cleansing technology in an anonymously processed electronic medical record database, the alliance will promote the analysis of medical big data with higher precision and the provision of services that support research and development in medical care. In the future, the companies will jointly promote the use of a variety medical and health data for its customers in Japan, including anonymously processed electronic medical record data.


TOPPAN Holdings has set "Digital & Sustainable Transformation" as its key concept, and one of its new business areas is the healthcare business. Among other initiatives, TOPPAN Holdings is driving digital transformation (DX) to promote the medical big data business with an analysis service based on anonymously processed electronic medical record data held by the Japan Medical Association Medical Information Management Organization (J-MIMO), a certified producer of anonymously processed medical information under the Next Generation Medical Infrastructure Act.

Under Fujitsu Uvance, which aims to realize a sustainable world, Fujitsu promotes "Healthy Living" focusing on improving the life experience of all people. To this end, Fujitsu has been advancing the utilization of data in the medical field by leveraging the code and master management methods of electronic medical record data, data cleansing technology cultivated in the electronic medical record system business, for which it has the top market share in Japan (2). Fujitsu also draws on its AI technologies including medical data analysis technology, unique expressions and relation extraction.

Partnership Overview

Through this partnership, the companies aim to increase the volume of data including anonymized electronic medical records used for data analysis, and to link the two companies' expertise in the use of medical data with their data platforms to provide more advanced analysis services for pharmaceutical companies and medical institutions.

Development and provision of data analysis services TOPPAN Holdings will introduce electronic medical record data anonymously processed by J-MIMO into its medical information analysis and provision service, “DATuM IDEA®”. Fujitsu's data cleansing platform helps to structure each hospital’s medical data in a different data format. This will enable highly accurate analysis, accelerate drug safety and efficacy evaluation, and contribute to more effective and efficient drug development and the realization of personalized medicine using databases. Fujitsu will develop SaaS analytics services for pharmaceutical companies and medical institutions using anonymized electronic medical record data. Aiming to improve the efficiency of the drug development process and improve the quality of medical care, Fujitsu will develop services such as medical data visualization and ad hoc analysis, promoting the use of medical AI models such as prediction and foreshadowing in research and development.Increase in electronic medical record data in data analysis Together with medical institutions and J-MIMO, the companies will collect previously unused data items, such as discharge summaries, nursing records, and surgical records, in addition to medically relevant information stored in electronic records, to increase the data used for analysis. This will contribute to the realization of personalized medicine by allowing administrators to grasp the individual patients’ conditions in more detail.Future Plans

The two companies will promote initiatives based on this alliance and contribute to the extension of healthy life expectancy and the realization of a sustainable society by jointly conducting analysis and research on electronic medical record data.

[1] Next Generation Medical Infrastructure Act :The official name is "Act on Anonymized Medical Data That Are Meant to Contribute to Research and Development in the Medical Field". A law to promote the use of anonymously processed medical information, such as medical examination results and medical records, in research and development in the medical field.
[2] The electronic medical record system business, which has the top market share in Japan :Based on "Hospital information system (HIS) operation status" in the "Medical Device System White Paper 2022" of M-E Promote Association Ltd.

About Fujitsu

Fujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$28 billion) for the fiscal year ended March 31, 2023 and remains the top digital services company in Japan by market share. Find out more:

About the TOPPAN Group

Established in Tokyo in 1900, the TOPPAN Group is a leading and diversified global provider committed to delivering sustainable, integrated solutions in fields including printing, communications, security, packaging, décor materials, electronics, and digital transformation. The TOPPAN Group’s global team of more than 50,000 employees offers optimal solutions enabled by industry-leading expertise and technologies to address the diverse challenges of every business sector and society and contribute to the achievement of shared sustainability goals.

Press Contacts:

Fujitsu Limited
Public and Investor Relations Division

TOPPAN Holdings
Public Relations Division

Topic: Press release summary
Source: Fujitsu Ltd

Sectors: MedTech
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Fujitsu Ltd Links

Fujitsu Ltd
May 23, 2024 09:18 HKT/SGT
'Fujitsu Technology and Service Vision 2024': Leveraging AI and leading-edge technologies to deliver greater value to the environment, economies and people's well-being
May 21, 2024 10:51 HKT/SGT
Fujitsu and Mizuho leverage AI to track trends in humpback whale migration and promote sustainable tourism for Hachijo Island
May 17, 2024 13:03 HKT/SGT
Fujitsu chosen for GENIAC project, starts development of large language models for logical reasoning
May 13, 2024 17:32 HKT/SGT
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
May 10, 2024 11:20 HKT/SGT
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 9, 2024 09:41 HKT/SGT
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 8, 2024 07:52 HKT/SGT
ServiceNow and Fujitsu announce strategic commitment to launch innovative cross-industry solutions
May 7, 2024 16:53 HKT/SGT
Fujitsu launches mainframe modernization automation service for the Japanese market
Apr 23, 2024 09:25 HKT/SGT
Fujitsu SX Survey reveals key success factors for sustainability
Apr 22, 2024 15:09 HKT/SGT
Fujitsu and METRON collaborate to drive ESG success: slashing energy costs, boosting productivity with new manufacturing industry solutions
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: